Loeper J, Descatoire V, Amouyal G, Lettéron P, Larrey D, Pessayre D
Unité de Recherches de Physiopathologie Hépatique, INSERM U 24, Hôpital Beaujon, Clichy, France.
Hepatology. 1989 May;9(5):675-8. doi: 10.1002/hep.1840090503.
Isaxonine and several other drugs transformed by cytochrome P-450 into reactive metabolites apparently lead to immunoallergic hepatitis in man. Protein epitopes modified by the covalent binding of the metabolites have been proposed as possible targets for the immune response. The purpose of this work was to determine whether covalently bound metabolites are indeed present on hepatocyte plasma membrane proteins. In a first series of experiments, rats were killed 15 or 60 min after administration of [2-14C]isaxonine (0.2 mmol.kg-1 i.p.), and various fractions were prepared from isolated hepatocytes; microsomal contamination of the plasma membrane fraction was 1.2% or less. At 60 min, the amount of isaxonine metabolite covalently bound per mg of protein was similar in plasma membranes (0.42 nmole metabolite.mg protein-1) and in microsomes (0.38); both values were decreased by about 70% in rats pretreated with piperonyl butoxide, an inhibitor of cytochrome P-450. At 15 min, however, covalent binding to plasma membrane proteins (0.06 nmole metabolite.mg protein-1) was only half of that to microsomal proteins (0.12). In a second series of experiments, [2-14C] isaxonine (0.1 mM) was incubated with NADPH, hepatic microsomes and plasma membranes. The reactive isaxonine metabolite became bound extensively to microsomal proteins, but not to plasma membrane proteins. These results show that administration of isaxonine leads to the presence of isaxonine adducts on the proteins of the hepatocyte plasma membrane.(ABSTRACT TRUNCATED AT 250 WORDS)
异沙尼定和其他几种经细胞色素P - 450转化为活性代谢产物的药物显然会导致人类免疫过敏性肝炎。代谢产物共价结合修饰的蛋白质表位被认为是免疫反应可能的靶点。这项研究的目的是确定共价结合的代谢产物是否确实存在于肝细胞质膜蛋白上。在第一系列实验中,给大鼠腹腔注射[2 - 14C]异沙尼定(0.2 mmol·kg-1)后15或60分钟处死大鼠,从分离的肝细胞中制备各种组分;质膜组分的微粒体污染率为1.2%或更低。60分钟时,每毫克蛋白质共价结合的异沙尼定代谢产物量在质膜(0.42纳摩尔代谢产物·毫克蛋白质-1)和微粒体(0.38)中相似;在用细胞色素P - 450抑制剂胡椒基丁醚预处理的大鼠中,这两个值均降低了约70%。然而,在15分钟时,与质膜蛋白的共价结合(0.06纳摩尔代谢产物·毫克蛋白质-1)仅为与微粒体蛋白共价结合量(0.12)的一半。在第二系列实验中,将[2 - 14C]异沙尼定(0.1 mM)与NADPH、肝微粒体和质膜一起孵育。活性异沙尼定代谢产物大量结合到微粒体蛋白上,但未结合到质膜蛋白上。这些结果表明,给予异沙尼定会导致肝细胞质膜蛋白上存在异沙尼定加合物。(摘要截短于250字)